The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
The microbiome and cancer
Open accessAbstract
Microbiota and host form a complex 'super-organism' in which symbiotic relationships confer benefits to the host in many key aspects of life. However, defects in the regulatory circuits of the host that control bacterial sensing and homeostasis, or alterations of the microbiome, through environmental changes (infection, diet or lifestyle), may disturb this symbiotic relationship and promote disease. Increasing evidence indicates a key role for the bacterial microbiota in carcinogenesis. In this Opinion article, we discuss links between the bacterial microbiota and cancer, with a particular focus on immune responses, dysbiosis, genotoxicity, metabolism and strategies to target the microbiome for cancer prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The microbial microenvironment is primarily comprised of intestinal and intra-tumoral microorganisms and their metabolites, which possess the ability to either facilitate or inhibit tumor progression and impact the effectiveness and toxicity of cancer treatments.329–332”
From Drug repurposing for cancer therapy (2024) · cites this paper as [332]
Experimental — accuracy not yet measuredIn the citing paper
“Exposure to broad-spectrum antibiotic (ATB) therapy may adversely influence outcomes of ICI therapy 2 through modulation of intestinal microbiota, 3 a key host determinant of response to ICIs known to precondition cancer-specific immunity.4”
From Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer (2019) · cites this paper as [4]
In the citing paper
“In particular, the regulation of such therapeutic outcome is tightly connected with the ability of the gut microbiota to metabolize anti-tumoral compounds, as well as to modulate host’s immune response and inflammation pathways [164].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Research works printed but not linked: 2
- Koch, R. in Tenth International Congress of Medicine 1 (August Hirschwald, Berlin, 1891).
- Laqueur, G. L., Matsumoto, H. & Yamamoto, R. S. Comparison of the carcinogenicity of methylazoxymethanol-β-D-glucosiduronic acid in conventional and germfree Sprague-Dawley rats. J. Natl Cancer Inst. 67, 1053–1055 (1981).
Cited by
Sorted by citations
Items 501–600 of 1,001
Hamada, K., Isobe, J., Hattori, K., Hosonuma, M., Baba, Y., Murayama, M., Narikawa, Y., Toyoda, H., Funayama, E., Tajima, K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1164724 · Cited by 56
Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies
Leal‐Lopes, C., Velloso, F. J., Campopiano, J. C., Sogayar, M. C., & Correa, R. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/284680 · Cited by 54
Atabati, H., Esmaeili, S., Saburi, E., Akhlaghi, M., Raoofi, A., Rezaei, N., & Momtazi‐Borojeni, A. A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29737 · Cited by 51
Impact of the microbiome on cancer progression and response to anti-cancer therapies
Rosean, C. B., Feng, T.-Y., Azar, F. N., & Rutkowski, M. R. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.005 · Cited by 52
Tumor microbiome metabolism: A game changer in cancer development and therapy
Zhou, X., Kandalai, S., Hossain, F., & Zheng, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933407 · Cited by 54
Integrative Approaches to the Treatment of Cancer
O’Brien, K., Ried, K., Binjemain, T., & Sali, A. (2022) · Cancers · doi:10.3390/cancers14235933 · Cited by 51
Tian, Z., Yu, Y., Fang, H., Xie, W., & Guo, M. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac634 · Cited by 51
Gut microbes modulate the effects of the flavonoid quercetin on atherosclerosis
Kasahara, K., Kerby, R. L., Aquino-Martínez, R., Evered, A. H., Cross, T.-W., Everhart, J., Ulland, T. K., Kay, C. D., Bolling, B. W., Bäckhed, F., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00626-1 · Cited by 55
Peralbo‐Molina, Á., Calderón-Santiago, M., Priego‐Capote, F., Gámez, B. J., & de Castro, M. D. L. (2016) · Journal of Breath Research · doi:10.1088/1752-7155/10/2/026002 · Cited by 51
Moen, B., Henjum, K., Måge, I., Knutsen, S. H., Rud, I., Hetland, R. B., & Paulsen, J. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155402 · Cited by 54
Liu, Y., Ji, C. B., Li, S. B., Yan, F., Gu, Q. S., Balic, J. J., Yu, L., & Li, J. K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.033 · Cited by 51
Canale, M. P., Noce, A., Lauro, M. D., Marrone, G., Cantelmo, M., Cardillo, C., Federici, M., Daniele, N. D., & Tesauro, M. (2021) · Nutrients · doi:10.3390/nu13041162 · Cited by 51
Metabolomics and the Multi-Omics View of Cancer
Wishart, D. S. (2022) · Metabolites · doi:10.3390/metabo12020154 · Cited by 57
Amiot, A., Mansour, H., Baumgaertner, I., Delchier, J., Tournigand, C., Furet, J., Carrau, J.-P., Canouï‐Poitrine, F., Sobhani, I., & for the CRC group of Val De Marne (2014) · PLoS ONE · doi:10.1371/journal.pone.0099233 · Cited by 52
Animal Models in Biomedical Research
Maurer, K. J., & Quimby, F. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-409527-4.00034-1 · Cited by 51
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
Lee, M. (2021) · Cancer Communications · doi:10.1002/cac2.12200 · Cited by 50
The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria
Wüthrich, I., Pelzer, B. W., Khodamoradi, Y., & Vehreschild, M. J. G. T. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1911279 · Cited by 50
Jacobson, D. K., Moore, K. N., Gunderson, C. C., Rowland, M. R., Austin, R. M., Honap, T. P., Xu, J., Warinner, C., Sankaranarayanan, K., & Lewis, C. M. (2021) · PeerJ · doi:10.7717/peerj.11574 · Cited by 50
Beneficial insights into postbiotics against colorectal cancer
Song, D., Wang, X., Ma, Y., Liu, N., & Wang, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1111872 · Cited by 52
The importance of cancer cells for animal evolutionary ecology
Frédéric Thomas, A., Jacqueline, C. M., Tissot, T., Henard, M., Blanchet, S., Loot, G., Dawson, E. H., Mery, F., Renaud, F., Montagne, J., et al. (2017) · Nature Ecology & Evolution · doi:10.1038/s41559-017-0343-z · Cited by 55
Rethinking the bile acid/gut microbiome axis in cancer
Phelan, J. P., Reen, F. J., Caparros-Martin, J. A., O’Connor, R., & O’Gara, F. (2017) · Oncotarget · doi:10.18632/oncotarget.22803 · Cited by 52
In situ biomolecule production by bacteria; a synthetic biology approach to medicine
Bueso, Y. F., Lehouritis, P., & Tangney, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.023 · Cited by 51
Kumar, R., Herold, J. L., Taylor, J. C., Xu, J., & Xu, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-19941-7 · Cited by 54
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
Cianci, R., Franza, L., Schinzari, G., Rossi, E., Ianiro, G., Tortora, G., Gasbarrini, A., Gambassi, G., & Cammarota, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030501 · Cited by 51
Son, S. J., Koh, J. H., Park, M., Ryu, S., Lee, W. J., Yun, B., Lee, J. H., Oh, S., & Kim, Y. (2019) · Journal of Dairy Science · doi:10.3168/jds.2018-15013 · Cited by 52
The potential role of P.gingivalis in gastrointestinal cancer: a mini review
Liu, X., Gao, Z.-Y., Sun, C., Wen, H., Gao, B., Li, S., & Tong, Q. (2019) · Infectious Agents and Cancer · doi:10.1186/s13027-019-0239-4 · Cited by 50
Long, Y., & Luo, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3066-0 · Cited by 50
Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer
Khan, S. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.05.002 · Cited by 50
Gapin, L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400119 · Cited by 50
The Impact of the Female Genital Microbiota on the Outcome of Assisted Reproduction Treatments
Cocomazzi, G., Stefani, S. D., Pup, L. D., Palini, S., Buccheri, M., Primiterra, M., Sciannamè, N., Faioli, R., Maglione, A., Baldini, G. M., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11061443 · Cited by 52
Filippou, C., Themistocleous, S., Marangos, G., Panayiotou, Y., Fyrilla, M., Kousparou, C. A., Pana, Z. D., Tsioutis, C., Johnson, E. O., & Yiallouris, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021110 · Cited by 49
Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease
Sharma, V., Singh, M. P., Kumar, V., Yadav, M. K., Sehrawat, N., Sharma, D. K., & Sharma, A. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.07.006 · Cited by 49
Oral Microbiota—A New Frontier in the Pathogenesis and Management of Head and Neck Cancers
Metsäniitty, M., Hasnat, S., Salo, T. A., & Salem, A. (2021) · Cancers · doi:10.3390/cancers14010046 · Cited by 50
Marongiu, L., & Allgayer, H. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13100 · Cited by 49
Role of the microbiome in oral cancer occurrence, progression and therapy
Li, Z., Liu, Y., & Zhang, L. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105638 · Cited by 51
Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma
Neto, A. G., Whitaker, A., & Pei, Z. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.005 · Cited by 48
Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics
Lindahl, A., Heuchel, R. L., Forshed, J., Lehtiö, J., Löhr, M. J., & Nordström, A. (2017) · Metabolomics · doi:10.1007/s11306-017-1199-6 · Cited by 48
Hernández-Jarguín, A., Sanchez, S. D., Villar, M., & de la Fuente, J. (2018) · Ticks and Tick-borne Diseases · doi:10.1016/j.ttbdis.2018.04.020 · Cited by 51
Kaelin, E. A., Skidmore, P. T., Łaniewski, P., Holland, L. A., Chase, D. M., Herbst‐Kralovetz, M. M., & Lim, E. S. (2022) · mSystems · doi:10.1128/msystems.00064-22 · Cited by 47
Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development
Nikolaieva, N., Ševčíková, A., Omelka, R., Martiniaková, M., Mego, M., & Čierniková, S. (2022) · Microorganisms · doi:10.3390/microorganisms11010107 · Cited by 47
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
Zha, C., Peng, Z., Huang, K., Tang, K., Wang, Q., Zhu, L. J., Che, B., Li, W., Xu, S., Huang, T., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1196217 · Cited by 49
Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer
Liu, Y., Baba, Y., Ishimoto, T., Iwatsuki, M., Hiyoshi, Y., Miyamoto, Y., Yoshida, N., Wu, R., & Baba, H. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1512-9 · Cited by 47
Chang, H.-H., & Eibl, G. (2019) · Cells · doi:10.3390/cells8070673 · Cited by 49
Association between the microbiota and women’s cancers – Cause or consequences?
Alizadehmohajer, N., Shojaeifar, S., Nedaeinia, R., Esparvarinha, M., Mohammadi, F., Ferns, G. A., Ghayour‐Mobarhan, M., Manian, M., & Balouchi, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110203 · Cited by 47
Xia, T., Zhang, B., Li, Y., Fang, B., Zhu, X., Xu, B., Zhang, J., Wang, M., & Fang, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112582 · Cited by 47
Dual Role of Bacteria in Carcinoma: Stimulation and Inhibition
Al-Hilu, S. A., & Al-Shujairi, W. H. (2020) · International Journal of Microbiology · doi:10.1155/2020/4639761 · Cited by 48
Gossip in the gut: Quorum sensing, a new player in the host-microbiota interactions
Coquant, G., Aguanno, D., Pham, S., Grellier, N., Thenet, S., Carrière, V., Grill, J.-P., & Seksik, P. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i42.7247 · Cited by 47
Association of periodontitis and tooth loss with liver cancer: A systematic review
Al‐Maweri, S. A., Ibraheem, W., Al-Ak’hali, M. S., Shamala, A., Halboub, E. S., & Alhajj, M. N. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103221 · Cited by 46
Microbiota in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Guan, D., Wang, Z., Li, X., Dong, S., Huang, J., & Zhou, W. (2023) · MedComm · doi:10.1002/mco2.417 · Cited by 47
Gallo, V., Arienzo, A., Tomassetti, F., & Antonini, G. (2024) · Foods · doi:10.3390/foods13060907 · Cited by 50
Wadan, A.-H. S., El‐Aziz, M. K. A., & Ellakwa, D. E. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04155-2 · Cited by 51
Belcheva, A., Irrazábal, T., & Martín, A. (2015) · BioEssays · doi:10.1002/bies.201400204 · Cited by 46
Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine
Contreras, A. V., Cocom-Chan, B., Hernández‐Montes, G., Portillo-Bobadilla, T., & Reséndis-Antonio, O. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00606 · Cited by 49
Risk of cancer in patients with constipation
Sundbøll, J., Thygesen, S. K., Veres, K., Liao, D., Zhao, J., Gregersen, H. N., & Sørensen, H. T. (2019) · Clinical Epidemiology · doi:10.2147/clep.s205957 · Cited by 47
Inoue, A., Deem, A. K., Kopetz, S., Heffernan, T. P., Draetta, G. F., & Carugo, A. (2019) · Cancers · doi:10.3390/cancers11091321 · Cited by 46
Gruffaz, M., Zhang, T., Marshall, V. A., Goncalves, P. H., Ramaswami, R., Labò, N., Whitby, D., Uldrick, T. S., Yarchoan, R., Huang, Y., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008114 · Cited by 46
Gut microbiota targeted nanomedicine for cancer therapy: Challenges and future considerations
Rajoka, M. S. R., Mehwish, H. M., Xiong, Y., Song, X., Hussain, N., Zhu, Q., & He, Z. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.10.036 · Cited by 47
Oral Bacterial Microbiota in Digestive Cancer Patients: A Systematic Review
Reitano, E., de’Angelis, N., Gavriilidis, P., Gaiani, F., Memeo, R., Inchingolo, R., Bianchi, G., de’Angelis, G. L., & Carra, M. C. (2021) · Microorganisms · doi:10.3390/microorganisms9122585 · Cited by 48
The Relationship Between Microbial Community and Breast Cancer
Song, X., Wei, C., & Li, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.849022 · Cited by 45
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence
Papakonstantinou, A., Nuciforo, P. G., Borrell, M., Zamora, E., Pimentel, I., Saura, C., & Oliveira, M. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102470 · Cited by 45
Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
He, Y., Huang, J., Li, Q., Xia, W., Zhang, C., Liu, Z., Xiao, J., Yi, Z., Deng, H., Xiao, Z., et al. (2022) · Cancers · doi:10.3390/cancers14215317 · Cited by 47
Ni, B., Kong, X., Yan, Y., Fu, B., Zhou, F., & Xu, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1091825 · Cited by 46
The microbial genotoxin colibactin exacerbates mismatch repair mutations in colorectal tumors
Dougherty, M. W., Valdés‐Mas, R., Wernke, K. M., Gharaibeh, R. Z., Yang, Y., Brant, J. O., Riva, A., Muehlbauer, M., Elinav, E., Puschhof, J., et al. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100918 · Cited by 47
Self-citationProbiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment
Thoda, C., & Touraki, M. (2023) · Microorganisms · doi:10.3390/microorganisms11081898 · Cited by 49
De-coding the complex role of microbial metabolites in cancer
Escriva, P. P., Bernardino, C. C. T., & Letellier, E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115358 · Cited by 48
The Intestinal Microbiome and the Liver Transplant Recipient
Doycheva, I., Leise, M. D., & Watt, K. D. S. (2015) · Transplantation · doi:10.1097/tp.0000000000001008 · Cited by 45
Cancer killers in the human gut microbiota: diverse phylogeny and broad spectra
Zhou, Y., Zhao, D., Liu, H., Chen, H., Li, J., Mu, X., Liu, Z., Li, X., Tang, L. M., Zhao, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17319 · Cited by 45
Exploring the microbiota to better understand gastrointestinal cancers physiology
Panebianco, C., Potenza, A., Andriulli, A., & Pazienza, V. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1163 · Cited by 46
Advanced In Vitro Testing Strategies and Models of the Intestine for Nanosafety Research
Kämpfer, A. A. M., Busch, M., & Schins, R. P. F. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00079 · Cited by 45
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Malla, R. R., Marni, R., Kumari, S., Chakraborty, A., & Pappu, L. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.09.002 · Cited by 44
von Frieling, J., Fink, C., Hamm, J., Klischies, K., Förster, M., Bosch, T. C. G., Roeder, T., Rosenstiel, P. C., & Sommer, F. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02020 · Cited by 45
Liu, Y., Li, Z., Qi, Y., Wen, X., & Zhang, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.795777 · Cited by 44
Tan, Y., Zou, J., Kuang, L., Wang, X., Zeng, B., Zhang, Z., & Wang, L. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-05053-7 · Cited by 43
Immune Therapy in GI Malignancies: A Review
Wang, J., Reiss, K. A., Khatri, R. G., Jaffee, E. M., & Laheru, D. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.7879 · Cited by 43
Mai, X., Genco, R. J., LaMonte, M. J., Hovey, K. M., Freudenheim, J. L., Andrews, C., & Wactawski‐Wende, J. (2015) · Journal of Periodontology · doi:10.1902/jop.2015.150433 · Cited by 43
Savić, N. D., Milivojević, D., Glišić, B. Đ., Tomic, T. I., Veselinović, J. B., Pavić, A., Vasiljević, B., Nikodinović‐Runić, J., & Djuran, M. I. (2016) · RSC Advances · doi:10.1039/c5ra26002g · Cited by 43
Porcine Models of Pancreatic Cancer
Bailey, K. L., & Carlson, M. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00144 · Cited by 43
Chen, L., Zhai, Y., Wang, Y., Fearon, E. R., Núñez, G., Inohara, N., & Cho, K. R. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0106 · Cited by 44
Wei, T.-T., Lin, Y., Tseng, R.-Y., Shun, C., Lin, Y., Wu, M., Fang, J., & Chen, C. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2379 · Cited by 43
Ventolini, G., Vieira‐Baptista, P., Seta, F. D., Verstraelen, H., Hoffmann, R., & Lev‐Sagie, A. (2021) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000646 · Cited by 42
γδ T Cells: Crosstalk Between Microbiota, Chronic Inflammation, and Colorectal Cancer
Yang, Y., Xu, C., Wu, D., Wang, Z., Wu, P., Li, L., Huang, J., & Qiu, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01483 · Cited by 43
Eco‐oncology: Applying ecological principles to understand and manage cancer
Reynolds, B. A., Oli, M. W., & Oli, M. K. (2020) · Ecology and Evolution · doi:10.1002/ece3.6590 · Cited by 42
Durán, C., Ciucci, S., Palladini, A., Ijaz, U. Z., Zippo, A. G., Sterbini, F. P., Masucci, L., Cammarota, G., Ianiro, G., Spuul, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22135-x · Cited by 43
Chen, C., Chen, L., Lin, L., Jin, D., Du, Y., & Lyu, J. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11358-z · Cited by 42
Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls
Aarnoutse, R., Hillege, L. E., Ziemons, J., de Vos‐Geelen, J., de Boer, M., Aerts, E. M. E. R., Vriens, B. E. P. J., van Riet, Y., Vincent, J., van de Wouw, A. J., et al. (2021) · Cancers · doi:10.3390/cancers13246200 · Cited by 42
Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma
Liao, Y., Zhang, J., Lu, L., Jia, Y., Zheng, M., Debelius, J. W., He, Y., Wang, T., Deng, C., Tong, X., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03448-22 · Cited by 41
Pattananandecha, T., Sirilun, S., Duangjitcharoen, Y., Sivamaruthi, B. S., Suwannalert, P., Peerajan, S., & Chaiyasut, C. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1110597 · Cited by 41
Urinary volatile organic compounds and faecal microbiome profiles in colorectal cancer
McFarlane, M. J., Millard, A. D., HALL, H. G., Savage, R. S., Constantinidou, C., Arasaradnam, R. P., & Nwokolo, C. U. (2019) · Colorectal Disease · doi:10.1111/codi.14739 · Cited by 41
Human microbiome and prostate cancer development: current insights into the prevention and treatment
Moghadam, S. O., & Momeni, S. A. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0731-7 · Cited by 41
Unmet Needs and Perspectives in Oral Cancer Prevention
Bouaoud, J., Bossi, P., Elkabets, M., Schmitz, S., van Kempen, L. C. L. T., Martinez, P., Jagadeeshan, S., Breuskin, I., Puppels, G. J., Hoffmann, C., et al. (2022) · Cancers · doi:10.3390/cancers14071815 · Cited by 41
Castelló, A., Rodríguez‐Barranco, M., de Larrea, N. F., Jakszyn, P. G., Dorronsoro, A., Amiano, P., Chirlaque, M., Colorado-Yohar, S. M., Guevara, M., Moreno‐Iribas, C., et al. (2022) · Nutrients · doi:10.3390/nu14153085 · Cited by 41
Lin, T.-C., Soorneedi, A., Guan, Y., Ying, T., Shi, E., Moore, M. D., & Liu, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1203087 · Cited by 41
Madison, J. D., Berg, E. A., Abarca, J. G., Whitfield, S. M., Gorbatenko, O. V., Pinto, A., & Kerby, J. L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00290 · Cited by 40
A marginalized two-part Beta regression model for microbiome compositional data
Chai, H., Jiang, H., Lin, L., & Liu, L. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006329 · Cited by 40
The role of microbiota in the pathogenesis of lupus: Dose it impact lupus nephritis?
Saadat, Y. R., Hejazian, S. M., Bastami, M., Khatibi, S. M. H., Ardalan, M., & Vahed, S. Z. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.023 · Cited by 40
Helicobacter pylori: Perturbation and restoration of gut microbiome
Saxena, A., Mukhopadhyay, A. K., & Nandi, S. P. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00078-7 · Cited by 40
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment
Khan, U., Ho, K., Hwang, E. K., Peña, C., Brouwer, J., Hoffman, K., Betel, D., Sonnenberg, G. F., Faltas, B. M., Saxena, A., et al. (2021) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000813 · Cited by 40
Dai, D., Yang, Y., Yang, Y., Dang, T., Xiao, J., Wang, W., Teng, L., Xu, J., Ye, J., & Jiang, H. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03167-9 · Cited by 40
An, J., Kwon, H., Lim, W., & Moon, B.-I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11072030 · Cited by 40
Gut Microbiome and Gastrointestinal Cancer
Tozun, N. A., & Vardareli, E. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000714 · Cited by 41
Metadata
- Authors
- Schwabe, R. F., & Jobin, C.
- Affiliations
- Columbia University (US)
- University of Florida Health (US)
- Corresponding author
- Schwabe, Robert F.
- Jobin, Christian
- Venue
- Nature Reviews Cancer
- Published
- 2013-10-17
- Volume
- 13
- Issue
- 11
- Pages
- 800-812
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3986062
- OpenAlex
- W2016853666
- Cited by
- 1,689
- References
- 205
- Citations by year
- 2026: 87 · 2025: 123 · 2024: 135 · 2023: 141 · 2022: 207 · 2021: 214 · 2020: 150 · 2019: 138 · 2018: 146 · 2017: 103 · 2016: 110 · 2015: 77 · 2014: 54
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (R01AA020211)
- National Cancer Institute (U54CA163111)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK047700, R01DK073338, R01DK076920)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- gut microbiota, carcinogenesis, dysbiosis, host-microbe symbiosis, bacterial sensing, immune response, genotoxicity, host metabolism, cancer prevention, microbiome-targeted therapy
- MeSH terms
- Animals, Bacteria, Diet, Humans, Immune System, Mutagens, Neoplasms, Symbiosis, Gene Expression Regulation, Bacterial, Gene Expression Regulation, Neoplastic, Virulence Factors, Mice, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review